It appears that Steve Jobs did not prescribe any new product pipeline, but it's clear the world's largest company by market cap has more than a few health-related aces up its sleeve.
While it's unclear what new products Apple may be developing, Creative Strategies President Tim Bajarin says health is likely the theme considering that its become a key part of its mobile platform, tying it closely with the iPhone and the Apple Watch.
"If Apple sees a hole in the health area that could benefit from a product they create that can tap into their hardware and device ecosystem, it makes sense for them to create that device," Bajarin said in an e-mail to TheStreet.
Despite the obvious health implications of the Apple Watch, CEO Timothy Cook told The Telegraph that it won't seek Food and Drug Administration approval for the wrist-held computer though it may do so for other products. "I wouldn't mind putting something adjacent to the watch through it, but not the watch, because it would hold us back from innovating too much, the cycles are too long," Cook said. "But you can begin to envision other things that might be adjacent to it - maybe an app, maybe something else."
"My view on Apple is unchanged," said TheStreet's Jim Cramer, portfolio manager of the Action Alerts PLUS Charitable Trust Portfolio. "Everyone seems to want to trade the stock and they should just own it as it is inexpensive and a great call on new products down the pipe."
As Apple has increased its research & development spending (it spent US$ 8.1 billion in fiscal 2015, up from US$ 6 billion in fiscal 2014 according to the company's most recent 10-K filing), it is clearly moving beyond smartphones, tablets and computers.
For starters, Apple has also been steadily increasing its supply-chain commitments over the years, suggesting it's not sitting back on its laurels.
Assuming Apple wanted to seek FDA regulation on an adjacent product to the Watch, it could be something used to diagnose or treat a specific disease. The Cupertino, California-based company would not be able to make a medical claim about benefits and risks without getting FDA approval first.
While it's unclear what new products Apple may be developing, Creative Strategies President Tim Bajarin says health is likely the theme considering that its become a key part of its mobile platform, tying it closely with the iPhone and the Apple Watch.
"If Apple sees a hole in the health area that could benefit from a product they create that can tap into their hardware and device ecosystem, it makes sense for them to create that device," Bajarin said in an e-mail to TheStreet.
Despite the obvious health implications of the Apple Watch, CEO Timothy Cook told The Telegraph that it won't seek Food and Drug Administration approval for the wrist-held computer though it may do so for other products. "I wouldn't mind putting something adjacent to the watch through it, but not the watch, because it would hold us back from innovating too much, the cycles are too long," Cook said. "But you can begin to envision other things that might be adjacent to it - maybe an app, maybe something else."
"My view on Apple is unchanged," said TheStreet's Jim Cramer, portfolio manager of the Action Alerts PLUS Charitable Trust Portfolio. "Everyone seems to want to trade the stock and they should just own it as it is inexpensive and a great call on new products down the pipe."
As Apple has increased its research & development spending (it spent US$ 8.1 billion in fiscal 2015, up from US$ 6 billion in fiscal 2014 according to the company's most recent 10-K filing), it is clearly moving beyond smartphones, tablets and computers.
For starters, Apple has also been steadily increasing its supply-chain commitments over the years, suggesting it's not sitting back on its laurels.
Assuming Apple wanted to seek FDA regulation on an adjacent product to the Watch, it could be something used to diagnose or treat a specific disease. The Cupertino, California-based company would not be able to make a medical claim about benefits and risks without getting FDA approval first.
Posts
0 comments
Post a Comment